By a GenomeWeb Staff Reporter
NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to commit $20.2 million to fund development of medical diagnostics, therapeutics, vaccines, and other technologies for use as countermeasures for pathogens and toxins.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: the Human Silencing Hub protein complex, and more.
Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.
The Kansas City Star examines issues surrounding newborn genome sequencing.
Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.